Thema: US61023L2079
MNPR, US61023L2079
money-6990721_1920.jpg - Foto: THN
Monopar Therapeutics stock holds at EUR 64.30 in late quote
Monopar Therapeutics stock was unchanged in the latest checked quote. The company is developing oncology radiopharmaceuticals and a Wilson Disease treatment.
ad-hoc-news.de, heute 02:28 Uhr
MNPR, US61023L2079
Monopar Therapeutics stock falls 5.60 percent below its ...
Analysts set a USD 122.00 target on October 11. Monopar Therapeutics stock costs EUR 65.80 on October 20, 2026, down 5.60 percent versus gettex.
ad-hoc-news.de, 20.10.26 22:12 Uhr
MNPR, US61023L2079
Monopar Therapeutics stock fell 3.52 percent on Nasdaq
Results are due on November 12, 2026. Monopar Therapeutics stock stood at USD 69.27 on October 16, 2026, down 3.52 percent on Nasdaq.
ad-hoc-news.de, 17.10.26 21:41 Uhr
MNPR, US61023L2079
Monopar Therapeutics stock faces insider selling after Q2 ...
